They have cut expenses by a lot while sales over the same period (as SEK) are still solid (3 months ending June was their 2nd best quarter ever and this was during thick of COVID). Also, they have diversified clients, not just in Australia. Achievement of Breakeven is going to be massive because reading through the past announcements, cash burn was the main issue.
- Forums
- ASX - By Stock
- Why I am Buying XF1 (XREF)
XF1
xref limited
Add to My Watchlist
0.00%
!
15.5¢

They have cut expenses by a lot while sales over the same period...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.11M |
Open | High | Low | Value | Volume |
15.5¢ | 15.5¢ | 15.0¢ | $81.94K | 528.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19847 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 2862 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19847 | 0.150 |
4 | 119000 | 0.130 |
1 | 500000 | 0.125 |
1 | 21000 | 0.120 |
2 | 77356 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 2862 | 1 |
0.165 | 154551 | 4 |
0.170 | 242000 | 2 |
0.180 | 41059 | 1 |
0.200 | 100000 | 1 |
Last trade - 12.04pm 18/06/2025 (20 minute delay) ? |
Featured News
XF1 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online